Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Sparrow has published a new paper in collaboration with the Victor Chang Cardiac Research Institute entitled "Gene-environment interaction impacts on heart development and embryo survival."

 

Congenital heart disease (CHD) is a heart defect that a baby is born with. It is the most common type of birth defect, affecting 1 in 100 babies worldwide, with about 12 affected babies born each day in the UK. Untreated, more than half of these will die. Such defects occur because something goes wrong as the baby’s heart forms in the womb. This can be because of faulty genes inherited from the parents, or it can be caused by environmental factors affecting the mother during pregnancy.

Most research in this area over the past 20 years has focused on understanding the genetic causes of CHD. However, even though the latest genome sequencing technologies have identified mutations in over 100 genes that can cause CHD, still only 20-30% of cases can be explained genetics alone.

Scientists at the Victor Chang Cardiac Research Institute in Sydney, Australia and DPAG's Duncan Sparrow have been studying how environmental factors might exacerbate the effects of genetic mutations to cause CHD. They have now shown that during normal pregnancy, mouse embryos lacking one copy of a gene associated with human CHD are completely normal, but when they are exposed to reduced oxygen levels in utero, their hearts form abnormally. This causes reduced heart rates and the sudden death of the embryos. They show that this is due to a normal cellular response to low oxygen levels acting pathologically to switch off the function of the remaining copy of the CHD-associated gene.

This work, partly funded by two British Heart Foundation grants, provides new evidence that some cases of CHD may be caused by the combination of genetic and environmental factors that each by itself does not cause a birth defect, but only do so when combined. This research may be applicable to prospective mothers with a family history of CHD, suggesting that it would be advisable for them to avoid known environmental risk factors for CHD.

Read the full paper published in Development here.

A summary is also available in the journal's "research highlights" section.

Similar stories

Genetic breakthrough to target care for deadly heart condition

CRE Research

Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.

Earliest origins of the forming heart identified

CRE Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

CRE Research

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

CRE Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

CRE Research

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.